CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-19 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2026-03-25 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +72,555 | 72,555 | ||
| 2026-01-24 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −535 | $8.44 | $5K | 2,981 |
| 2025-01-31 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2025-01-24 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −6,270 | $0.92 | $6K | 56,241 |
| 2024-06-05 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +336,911 | 336,911 | ||
| 2024-01-24 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −3,565 | $2.40 | $9K | 42,811 |
| 2024-01-24 | Aftab Blake Chief Scientific Officer | Grant or award | +19,700 | 62,511 | ||
| 2024-01-24 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +241,173 | 241,173 | ||
| 2023-10-12 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −7,933 | $1.35 | $11K | 46,376 |
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −56,612 | 0 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +56,612 | 56,612 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −117,200 | 0 | ||
| 2023-08-14 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +117,200 | 117,200 |
Page 1 of 3 · 41 trades